Why has Medicaid stopped paying for Strattera?

Medicaid has stopped paying for Strattera due to concerns about its cost-effectiveness and the availability of alternative treatments for Attention Deficit Hyperactivity Disorder (ADHD). Many states are re-evaluating their formularies to prioritize medications that provide better outcomes at lower costs. Additionally, changes in clinical guidelines and the push for evidence-based prescribing may have influenced this decision. Patients affected by this change may need to consult with their healthcare providers for alternative treatment options.